You are here

Novartis

ACC 2021: Novartis looks for silver linings in Entrestro’s narrow loss to an ACE inhibitor in heart attack patients

Fierce Pharma

Sat, 05/15/21 - 11:00 pm

Biopharma Companies Wrestle with Staffing Situations and Shortages from Pandemic

BioSpace

Thu, 04/29/21 - 10:45 pm

Moderna Therapeutics

Zolgensma flatlines, but Spinraza isn’t the beneficiary

EP Vantage

Wed, 04/28/21 - 10:27 am

Novartis Generics Face 'Challenging Quarter,' But Gene Therapy Shines

Investors Business Daily

Tue, 04/27/21 - 11:20 pm

Now reimagining home, office schedules: Novartis CEO Vas Narasimhan sees a new normal in the post-Covid era

Endpoints

Tue, 04/27/21 - 10:56 am

Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra

Fierce Pharma

Thu, 04/15/21 - 11:21 am

Genentech and Novartis Win FDA Approval for Self-Injectable Form of Xolair

BioSpace

Tue, 04/13/21 - 10:03 pm

Novartis expands in radio-oncology again with $1.3bn Artios alliance

Pharmaforum

Wed, 04/7/21 - 10:35 am

precision medicine

Novartis dives even deeper into radioligands, notching licensing deal with iTheranostics for multiple compounds

Endpoints

Tue, 03/30/21 - 11:40 am

Novartis pushes back on chairman's 'inaccurate and inconsistent' comments undermining bribery settlement

Endpoints

Fri, 03/26/21 - 10:54 am

Novartis is shutting down Colorado plant, laying off 400 employees after overestimating gene therapy demand

Fierce Pharma

Thu, 03/25/21 - 11:18 am

drug manufacturing

Novartis' radioligand hits goal in phase 3 prostate cancer trial

Fierce Biotech

Tue, 03/23/21 - 10:29 am

prostate cancer

clinical trials

J&J nabs FDA nod for Ponvory, joining Novartis, Bristol Myers in crowded MS market

Fierce Pharma

Fri, 03/19/21 - 10:56 am

Bristol-Myers Squibb

multiple sclerosis

Are radiopharmaceuticals ready for the mainstream? Novartis, Bristol Myers Squibb bet yes on MPM's platform take

Endpoints

Thu, 03/18/21 - 10:51 am

radiopharmaceuticals

Bristol Myers Squibb

Eli Lilly, Novartis back a biotech startup boasting 'best of both worlds' protein degraders

Endpoints

Wed, 03/17/21 - 10:30 am

protein degradation

Novartis’ Autoimmune Drug Not Up for the Challenge in Phase III Cancer Trial

BioSpace

Tue, 03/9/21 - 09:47 pm

clinical trials

metastatic non-small cell lung cancer

Novartis sues FDA over its stance on Sanofi blockbuster’s exclusivity

Endpoints

Tue, 03/9/21 - 10:49 am

multiple sclerosis

Setback for Novartis drug in advanced lung cancer trial

Biopharma Reporter

Tue, 03/9/21 - 10:40 am

clinical trials

metastatic non-small cell lung cancer

Novartis exec says Kymriah's ready to square off with Bristol Myers' new CAR-T rival Breyanzi

Fierce Pharma

Sun, 03/7/21 - 01:29 pm

Bristol Myers Squibb

Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda

Fierce Pharma

Thu, 03/4/21 - 11:21 pm

non-small cell lung cancer

Pages